Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Cell Physiol ; 234(2): 1689-1698, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30070693

RESUMO

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a master regulator for the induction of antioxidative genes and plays roles in diverse cellular functions. The roles of Nrf2 in muscle regeneration have been investigated, and both important and unimportant roles of Nrf2 for muscle regeneration have been reported. Here, using aged Nrf2-null and Nrf2-dystrophic double-null mice, we showed nonsignificant phenotypes in the muscle regeneration ability of Nrf2-null mice. In contrast with these results, strikingly, almost all Nrf2-null muscle stem cells (MuSCs) isolated by fluorescence-activated cell sorting died in vitro of apoptosis and were not rescued by antioxidative reagents. Although their proliferation was still impaired, the Nrf2-null MuSCs attached to myofibers activated and divided normally, at least in the first round. To elucidate these discrepancies of MuSCs behaviors, we focused on the basal lamina, because both in vivo and single myofiber culture allow MuSCs within the basal lamina to become activated. In a basal lamina-disrupted model, Nrf2-null mice exhibited remarkable regeneration defects without increased levels of reactive oxidative species in MuSCs, suggesting that the existence of the basal lamina affects the survival of Nrf2-null MuSCs. Taken together, these results suggest that the basal lamina compensates for the loss of Nrf2, independent of the antioxidative roles of Nrf2. In addition, experimental conditions might explain the discrepant results of Nrf2-null regenerative ability.


Assuntos
Membrana Basal/metabolismo , Desenvolvimento Muscular , Músculo Esquelético/metabolismo , Fator 2 Relacionado a NF-E2/deficiência , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Células Satélites de Músculo Esquelético/metabolismo , Animais , Apoptose , Técnicas de Cultura de Células , Proliferação de Células , Sobrevivência Celular , Células Cultivadas , Colágeno/metabolismo , Combinação de Medicamentos , Laminina/metabolismo , Camundongos Endogâmicos mdx , Camundongos Knockout , Músculo Esquelético/patologia , Fator 2 Relacionado a NF-E2/genética , Proteoglicanas/metabolismo , Regeneração , Células Satélites de Músculo Esquelético/patologia , Transdução de Sinais
2.
PLoS One ; 13(10): e0205467, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30300394

RESUMO

Cancer cachexia is a severe, debilitating condition characterized by progressive body wasting associated with remarkable loss of skeletal muscle weight. It has been reported that cancer cachexia disturbs the regenerative ability of skeletal muscle, but the cellular mechanisms are still unknown. Here, we investigated the skeletal muscle regenerative process in mouse colon-26 (C26) tumor cell-bearing mice as a C26 cancer cachexia model. Although the proliferation and differentiation abilities of muscle stem cells derived from the C26 tumor cell-bearing mice were sustained in vitro, the proliferation and differentiation were severely impaired in the cachexic mice. The numbers of both macrophages and mesenchymal progenitors, which are critical players in muscle regeneration, were reduced in the cancer cachexic mice, indicating that the skeletal muscle regeneration process was disrupted by cancer cachexia. Furthermore, the number of infiltrated neutrophils was also reduced in cancer cachexia mice 24 hours after muscle injury, and the expression of critical chemokines for muscle regeneration was reduced in cancer cachexia model mice compared to control mice. Collectively, although the ability to regeneration of MuSCs was retained, cancer cachexia disturbed skeletal muscle regenerative ability by inhibiting the orchestrated muscle regeneration processes.


Assuntos
Neoplasias do Colo/patologia , Músculo Esquelético/fisiologia , Regeneração , Tecido Adiposo/patologia , Animais , Caquexia/etiologia , Diferenciação Celular , Linhagem Celular Tumoral , Proliferação de Células , Quimiocinas/metabolismo , Proteínas Cardiotóxicas de Elapídeos/farmacologia , Crotoxina/farmacologia , Modelos Animais de Doenças , Regulação para Baixo , Combinação de Medicamentos , Camundongos , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/patologia , Infiltração de Neutrófilos , Regeneração/efeitos dos fármacos , Células-Tronco/citologia , Células-Tronco/metabolismo , Transplante Heterólogo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA